12.94 USD
▲+0.72+3.03%
盘后 12.46 -0.80%
2026-08-03
市值
$936.54M
市盈率
10.70
EPS
1.21
股息率
—
52 周区间
3.44 – 17.65
成交量
1.65M
Beta
2.52
目标价
33.00
52W 低 3.4452W 高 17.65
价格走势
公司简介
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company’s lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has completed phase I clinical trials for mannan-bind...